AT106239T - Preparations with controlled drug delivery. - Google Patents

Preparations with controlled drug delivery.

Info

Publication number
AT106239T
AT106239T AT89120607T AT89120607T AT106239T AT 106239 T AT106239 T AT 106239T AT 89120607 T AT89120607 T AT 89120607T AT 89120607 T AT89120607 T AT 89120607T AT 106239 T AT106239 T AT 106239T
Authority
AT
Austria
Prior art keywords
preparations
drug delivery
controlled drug
controlled
delivery
Prior art date
Application number
AT89120607T
Other languages
German (de)
Inventor
Yohko Akiyama
Hidetoshi Horibe
Minoru Yoshioka
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP28299488 priority Critical
Priority to JP29437988 priority
Priority to JP1259674A priority patent/JP2893191B2/en
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AT106239T publication Critical patent/AT106239T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
AT89120607T 1988-11-08 1989-11-07 Preparations with controlled drug delivery. AT106239T (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP28299488 1988-11-08
JP29437988 1988-11-21
JP1259674A JP2893191B2 (en) 1988-11-08 1989-10-03 Controlled release matrix dosage

Publications (1)

Publication Number Publication Date
AT106239T true AT106239T (en) 1994-06-15

Family

ID=27334835

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89120607T AT106239T (en) 1988-11-08 1989-11-07 Preparations with controlled drug delivery.

Country Status (8)

Country Link
EP (1) EP0368247B1 (en)
AT (1) AT106239T (en)
AU (2) AU645003B2 (en)
CA (1) CA2002363C (en)
DE (2) DE68915695T2 (en)
DK (1) DK555389A (en)
HU (1) HU211615A9 (en)
NZ (1) NZ231281A (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (en) * 1990-03-23 1993-12-29 Chiesi Farma Spa Pharmaceutical compositions containing ipriflavone, process for their preparation and its therapeutic use
EP0452145B1 (en) * 1990-04-12 1996-11-13 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. Coated composition and its preparation process
US5290569A (en) * 1990-04-12 1994-03-01 Shionogi & Co., Ltd. Coated composition and its preparation process
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
DE69222847T3 (en) * 1991-04-16 2005-09-15 Nippon Shinyaku Co., Ltd. Process for preparing a solid dispersion
TW209174B (en) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
DE4131562A1 (en) * 1991-09-18 1993-03-25 Medac Klinische Spezialpraep Arzneistofftraeger of solid lipid particles-solid lipidnanosphaeren (sln)
YU87892A (en) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injectable slow-release formulations and methods for their preparation and use
MX9300110A (en) * 1992-01-13 1994-07-29 Gerhard Gergely Pharmaceutical preparation in the form of a tablet or effervescent disintegration or granules instanteneo type and process for their preparation.
AU2584092A (en) * 1992-09-03 1994-03-29 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
AT223704T (en) * 1992-10-16 2002-09-15 Nippon Shinyaku Co Ltd A process for preparing wachsmatrizes
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5849240A (en) * 1993-11-23 1998-12-15 Euro-Celtique, S.A. Method of preparing sustained release pharmaceutical compositions
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
JPH07112940A (en) * 1993-08-26 1995-05-02 Takeda Chem Ind Ltd Sustained-release parenteral preparation and its production
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU6422798A (en) * 1997-03-25 1998-10-20 Takeda Chemical Industries Ltd. Stabilized urease inhibitor
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6423345B2 (en) 1998-04-30 2002-07-23 Acusphere, Inc. Matrices formed of polymer and hydrophobic compounds for use in drug delivery
DE19918325A1 (en) 1999-04-22 2000-10-26 Euro Celtique Sa Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
JP4310605B2 (en) * 2001-05-25 2009-08-12 大塚製薬株式会社 Pharmaceutical composition
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
SE0200475D0 (en) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral pharmaceutical preparation
SE0201922D0 (en) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande composition (Composition Anticoagulant)
AU2005320547B2 (en) 2005-02-18 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060275228A1 (en) * 2005-05-09 2006-12-07 Bissett Donald L Skin care compositions containing idebenone
WO2010103539A2 (en) 2009-03-09 2010-09-16 Dinesh Shantilal Patel Sustained release oral formulation of vinpocetine
WO2011121989A1 (en) * 2010-03-29 2011-10-06 株式会社カネカ Coating fat composition and particulate composition using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857933A (en) * 1969-10-17 1974-12-31 Hoechst Ag Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
DE3224619C2 (en) * 1981-07-14 1990-10-04 Freund Industrial Co., Ltd., Tokio/Tokyo, Jp
JPS5951214A (en) * 1982-09-16 1984-03-24 Furointo Sangyo Kk Preparation of drug having high bioavailability
DE3524003A1 (en) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Drug granules sustained release and process for its manufacture
CA1331559C (en) * 1986-04-21 1994-08-23 Jon Joseph Kabara Antimicrobial preservative compositions and methods
JP2818220B2 (en) * 1988-11-04 1998-10-30 フロイント産業株式会社 Water-containing organic solvent extract containing compositions for food and water-containing organic solvent extract containing compositions for pharmaceutical, and methods for their preparation

Also Published As

Publication number Publication date
DK555389D0 (en) 1989-11-07
DE68915695T2 (en) 1994-09-15
DK555389A (en) 1990-05-09
AU4443789A (en) 1990-06-21
CA2002363C (en) 1999-09-07
CA2002363A1 (en) 1990-05-08
AU3856193A (en) 1993-08-26
DE68915695D1 (en) 1994-07-07
NZ231281A (en) 1991-01-29
EP0368247A2 (en) 1990-05-16
HU211615A9 (en) 1995-12-28
AU645003B2 (en) 1994-01-06
EP0368247A3 (en) 1991-05-08
EP0368247B1 (en) 1994-06-01

Similar Documents

Publication Publication Date Title
DE3873275D1 (en) Temperature-controlled drug dispensers.
DE69117793D1 (en) Medication infusion system
DE68910383D1 (en) Selbstabschliessende intravascular cannula.
DE68917895D1 (en) Catheter.
DE68906278T2 (en) Retractable disposable syringe.
MX9203480A (en) AEREOSOL medicinal formulations.
AT106241T (en) Pharmaceutical preparation with controlled release.
DE68916015D1 (en) Double-fluid supply system.
DE3885439D1 (en) Catheter.
DE68902344D1 (en) Medicines with good stability.
DE69224619T2 (en) Drug delivery system
DK186089D0 (en) syringes
NO882565L (en) Generic zero-order drug delivery system.
DE68915380D1 (en) System for administering medicaments.
DE3669103D1 (en) Ibuprofen-containing drug.
DE3774695D1 (en) Abrasion Solid fertilizers with controlled administration.
DE3882848T2 (en) Cosmetic base formulation with drug properties.
DE69009049T2 (en) Infusion pump.
DE3781928D1 (en) Sustained release drug.
DE69113847T2 (en) Syringe with the displayed dose.
DE68928626D1 (en) The implantable infusion device
DE3869124D1 (en) Drug delivery cartridge with protective cover.
DE3885018T2 (en) Syringe.
NO905125L (en) Administration device.
DE3780223T2 (en) Drug controlled release.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee